Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PPH vs. IHE: which is better?

Bottom line

PPH vs IHE: the short answer

PPH (VanEck Pharmaceutical ETF) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 43% by weight.

But IHE is far broader, holding 59 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.

PPH is cheaper at 0.36% vs 0.37% — a difference of $1.00 a year per $10,000 invested.

Over five years, PPH returned +11.3% a year vs +9.1% for IHE.

Updated Nov 19, 2026

PPH vs IHE side by side

PPHIHE
TypeETFETF
Fund familyVanEckiShares
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.36%0.37%
Annual cost per $10k$36$37
10-yr cost on $10k (prospectus)$456$468
Max front loadNoneNone
12b-1 fee—0%
1-yr return+21.9%+31.7%
5-yr return (annualized)+11.3%+9.1%
10-yr return (annualized)+6.7%+6.2%
Best quarter+16.5%+17.6%
Worst quarter−15.0%−16.0%
Net assets (fund)$879.5M$1.1B
Number of holdings2659
Portfolio turnover3%29%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearPPHIHEDifference
2025+21.9%+31.7%−9.8%
2024+8.1%+8.1%+0.1%
2023+6.9%+1.0%+5.9%
2022+2.6%−4.8%+7.4%
2021+18.3%+12.8%+5.5%
2020+5.2%+13.8%−8.6%
2019+19.1%+15.5%+3.6%
2018−5.7%−7.7%+2.0%
2017+15.4%+10.7%+4.7%
2016−17.8%−11.7%−6.0%

Source: Fund prospectus bar charts

Holdings overlap

11 of PPH's top 25 holdings also appear in IHE's top 25.

Shared top holdings
HoldingPPHIHE
Eli Lilly & Co20.23%22.25%
Merck & Co Inc9.85%4.55%
Pfizer Inc4.51%3.96%
Bristol-Myers Squibb Co4.47%4.37%
Johnson & Johnson4.35%22.44%
Zoetis Inc2.10%3.73%
Viatris Inc1.10%4.22%
Axsome Therapeutics Inc0.77%2.42%
Corcept Therapeutics Inc0.50%1.90%
Elanco Animal Health Inc0.35%2.81%
Organon & Co0.23%0.81%

Source: SEC Form N-PORT

PPH top 10

  1. Eli Lilly & Co — 20.23%
  2. Novartis AG — 10.63%
  3. Merck & Co Inc — 9.85%
  4. Novo Nordisk A/S — 5.37%
  5. AbbVie Inc — 4.57%
  6. Pfizer Inc — 4.51%
  7. Bristol-Myers Squibb Co — 4.47%
  8. Gsk Plc — 4.42%
  9. Johnson & Johnson — 4.35%
  10. AstraZeneca PLC — 4.33%

IHE top 10

  1. Johnson & Johnson — 22.44%
  2. Eli Lilly And Company — 22.25%
  3. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
  4. Merck & Co., Inc. — 4.55%
  5. Bristol-myers Squibb Company — 4.37%
  6. Royalty Pharma Plc — 4.34%
  7. Viatris Inc. — 4.22%
  8. Pfizer Inc. — 3.96%
  9. Zoetis Inc. — 3.73%
  10. Jazz Pharmaceuticals Public Limited Company — 3.45%

FAQ

What is the difference between PPH and IHE?
PPH (VanEck Pharmaceutical ETF) and IHE (iShares U.S. Pharmaceuticals ETF) share a meaningful slice of their top holdings — about 43% by weight. But IHE is far broader, holding 59 positions to 26 for PPH, so beyond the top names it adds exposure PPH doesn't have.
Which is cheaper, PPH or IHE?
PPH has the lower expense ratio (0.36%).
Should I own both PPH and IHE?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.